| Literature DB >> 21547065 |
Da-Ji Luo1, Wei Hu, Shang-Ping Chen, Zuo-Yan Zhu.
Abstract
Somatic cell nuclear transfer (SCNT) has been performed extensively in fish since the 1960s with a generally low efficiency of approximately 1%. Little is known about somatic nuclear reprogramming in fish. Here, we utilized the zebrafish as a model to study reprogramming events of nuclei from tail, liver and kidney cells by SCNT. We produced a total of 4,796 reconstituted embryos and obtained a high survival rate of 58.9-67.4% initially at the 8-cell stage. The survival rate exhibited two steps of dramatic decrease, leading to 8.7-13.9% at the dome stage and to 1.5-2.96% by the shield stage. Concurrently, we observed that SCNT embryos displayed apparently delayed development also at the two stages, namely the dome stage (1:30 ± 0:40) and the shield stage (2:50 ± 0:50), indicating that the dome and shield stage are critical for the SCNT efficiency. Interestingly, we also revealed that an apparent alteration in klf4 and mycb expression occurred at the dome stage in SCNT embryos from all the three donor cell sources. Taken together, these results suggest that the dome stage is critical for the SCNT efficiency, and that alternated gene expression appears to be common to SCNT embryos independently of the donor cell types, suggesting that balanced mycb and klf4 expression at this stage is important for proper reprogramming of somatic nuclei in zebrafish SCNT embryos. Although the significant alteration in klf4 and mycb expression was not identified at the shield stage between ZD and SCNT embryos, the importance of reprogramming processes at the shield stage should not be underestimated in zebrafish SCNT embryos.Entities:
Keywords: SCNT; dome stage; klf4 and mycb; reprogramming; shield stage
Mesh:
Substances:
Year: 2011 PMID: 21547065 PMCID: PMC3088290 DOI: 10.7150/ijbs.7.476
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Nuclear transplants generated using kidney cells
| No. Of Egg operated | No. Of 2-cell stage | No. Of 8-cell stage | No. Of 256-cell stage | No. Of High stage | No. Of Dome stage | No. Of 30% Epiboly | No. Of Shield stage | No. Of 75% Epiboly |
|---|---|---|---|---|---|---|---|---|
| (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
| 405 (Exp.1) | 271 | 257 | 211 | 197 | 55 | 51 | 12 | 2 |
| (66.91) | (63.45) | (52.10) | (48.64) | (13.58) | (12.59) | (2.96) | (0.49) | |
| 539 (Exp.2) | 375 | 344 | 273 | 253 | 70 | 62 | 14 | 2 |
| (69.57) | (63.82) | (50.65) | (46.94) | (12.99) | (11.50) | (2.60) | (0.37) | |
| 567 (Exp.3) | 398 | 382 | 299 | 286 | 79 | 77 | 16 | 3 |
| (70.19) | (67.37) | (52.73) | (50.44) | (13.93) | (13.58) | (2.82) | (0.53) |
Nuclear transplants generated using liver cells
| No. Of Egg operated | No. Of 2-cell stage | No. Of 8-cell stage | No. Of 256-cell stage | No. Of High stage | No. Of Dome stage | No. Of 30% Epiboly | No. Of Shield stage | No. Of 75% Epiboly |
|---|---|---|---|---|---|---|---|---|
| (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
| 387 (Exp.1) | 266 | 228 | 201 | 190 | 49 | 46 | 8 | 1 |
| (68.73) | (58.91) | (51.94) | (49.09) | (12.66) | (11.89) | (2.06) | (0.25) | |
| 520 (Exp.2) | 342 | 317 | 263 | 247 | 58 | 58 | 13 | 1 |
| (65.77) | (60.96) | (50.57) | (47.50) | (11.15) | (11.15) | (2.50) | (0.19) | |
| 312 (Exp.3) | 210 | 196 | 164 | 151 | 38 | 36 | 7 | 1 |
| (67.31) | (62.82) | (52.56) | (48.40) | (12.18) | (11.54) | (2.24) | (0.14) |
Nuclear transplants generated using tail cells
| No. Of Egg operated | No. Of 2-cell stage | No. Of 8-cell stage | No. Of 256-cell stage | No. Of High stage | No. Of Dome stage | No. Of 30% Epiboly | No. Of Shield stage | No. Of 75% Epiboly |
|---|---|---|---|---|---|---|---|---|
| (%) | (%) | (%) | (%) | (%) | (%) | (%) | (%) | |
| 587 (Exp.1) | 391 | 348 | 261 | 233 | 51 | 49 | 9 | 1 |
| (66.61) | (59.28) | (44.46) | (39.69) | (8.69) | (8.35) | (1.53) | (0.17) | |
| 767 (Exp.2) | 512 | 465 | 346 | 317 | 72 | 70 | 14 | 2 |
| (66.75) | (60.63) | (45.11) | (41.33) | (9.39) | (9.13) | (1.83) | (0.26) | |
| 712 (Exp.3) | 486 | 433 | 343 | 319 | 63 | 62 | 11 | 1 |
| (68.26) | (60.81) | (48.17) | (44.80) | (8.85) | (8.71) | (1.54) | (0.14) |
Figure 1The morphology of zebrafish SCNT embryos during the blastulae period. (A) The normal morphology of zebrafish SCNT embryos in the blastulae period; (B-D) The abnormal morphology of zebrafish SCNT embryos in blastulae period; part of the animal pole cells of these SCNT embryos did not participate in the development of SCNT embryos.
Figure 2The abnormal morphology of zebrafish SCNT embryos during the gastrula period. (A-C) The abnormal morphology of zebrafish SCNT embryos at the 40% to 50% epiboly stage; (D) The abnormal morphology of zebrafish SCNT embryos at the 80% epiboly stage.
Developmental timing (hour:min) of nuclear transplantsa.
| 2-cell stage | 8-cell stage | 256-cell stage | High stage | Dome stage | 30% Epiboly | Shield stage | 75% Epiboly | |
|---|---|---|---|---|---|---|---|---|
| ZD embryos | 0:45 | 1:15 | 2:30 | 3:20 | 4:20 | 4:40 | 6:00 | 8:00 |
| KC SCNT embryosb | 0:50±0:05 | 1:25±0:05 | 2:40±0:05 | 3:50±0:10 | 5:30±0:20; ∞ | 5:55±0:30; ∞ | 8:30±0:50; ∞ | 10:45±1:00; ∞ |
| LC SCNT embryosc | 0:50±0:05 | 1:25±0:05 | 2:40±0:05 | 3:50±0:10 | 5:30±0:25; ∞ | 5:55±0:30; ∞ | 8:35±0:50; ∞ | 11:00±1:00; ∞ |
| TC SCNT embryosd | 0:50±0:05 | 1:25±0:05 | 2:50±0:10 | 4:00±0:20 | 5:50±0:40; ∞ | 6:30±0:40; ∞ | 8:50±0:50; ∞ | 11:30±1:00; ∞ |
a Each stage except the shield stage and 75% epiboly includes samples beyond 30 embryos, the timing is the average timing of this stage adjusted by the floating range;
b KC SCNT embryos: kidney cell derived SCNT embryos;
c LC SCNT embryos: liver cell derived SCNT embryos;
d TC SCNT embryos: tail cell derived SCNT embryos;
∞: embryos developed in several hours without any morphological changes until death.
Figure 3Gene expression between SCNT embryos and ZD embryos by semi-quantitative RT-PCR analysis. RNA expression was identified using RT-PCR during three developmental stages of zebrafish embryos among ZD embryos, KC SCNT embryos, LC SCNT embryos and TC SCNT embryos. (A) The relative expression of klf4 and mycb gene at the cleavage stage; (B) The relative expression of klf4 and mycb gene at the dome stage; (C) The relative expression of klf4 and mycb gene at the shield stage.
Figure 4Real-time RT-PCR analyses of klf4 and mycb gene expression. RNA expression was identified using real-time RT-PCR among ZD embryos, KC SCNT embryos, LC SCNT embryos and TC SCNT embryos at the dome stage. (A) Gene klf4. (B) Gene mycb. Data are means ± s.d (bars above columns) of three samples; *, 0.01≤p ≤0.05; **, p ≤0.01.